<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-R5UI2R5M</identifier><date>2022</date><creator>Kovačič, Alenka</creator><relation>documents/doc/R/URN_NBN_SI_doc-R5UI2R5M_001.pdf</relation><relation>documents/doc/R/URN_NBN_SI_doc-R5UI2R5M_001.txt</relation><format format_type="issue">2</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 141-146</format><identifier identifier_type="COBISSID_HOST">140694787</identifier><identifier identifier_type="ISSN">2536-4316</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-R5UI2R5M</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">aplikacija inzulina</subject><subject language_type_id="slv">aspart</subject><subject language_type_id="slv">degludek</subject><subject language_type_id="slv">glikemija</subject><subject language_type_id="slv">glulisin</subject><subject language_type_id="eng">glulisine</subject><subject language_type_id="eng">glycemia</subject><subject language_type_id="eng">insulin administration</subject><subject language_type_id="slv">Inzulin</subject><subject language_type_id="slv">Sladkorna bolezen</subject><title>Insulins for the treatment of diabetes – novelties and special features</title><title>Inzulini za zdravljenje sladkorne bolezni – novosti in posebnosti</title></Record>